Cogent Biosciences Inc’s recent filing unveils that its Chief Commercial Officer Pinnow Cole acquired Company’s shares for reported $0.33 million
Cogent Biosciences Inc’s filing revealed that its Chief Commercial Officer Pinnow Cole acquired Company’s shares for reported $0.33 million on
Cogent Biosciences Inc’s filing revealed that its Chief Commercial Officer Pinnow Cole acquired Company’s shares for reported $0.33 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its